Weide, Benjamin
Martens, Alexander
Wistuba-Hamprecht, Kilian
Zelba, Henning
Maier, Ludwig
Lipp, Hans-Peter
Klumpp, Bernhard D.
Soffel, Daniel
Eigentler, Thomas K.
Garbe, Claus
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 20 September 2016
Accepted: 8 December 2016
First Online: 22 December 2016
Compliance with ethical standards
:
: B Weide reports receiving commercial research grants from Bristol–Myers Squibb (BMS) and MSD Sharp and Dohme (MSD) and reports receiving travel/accommodations/expenses from BMS, MSD, Roche, Amgen, Philogen, Curevac and compensated advisory services for MSD, BMS, Philogen and Curevac. C. Garbe reports receiving honoraria from BMS, MSD, Amgen, Novartis, Roche, GlaxoSmithKline (GSK) and reports receiving commercial research grants from MSD, BMS, Roche, GSK. T.K Eigentler reports receiving honoraria from BMS, MSD, Roche and Novartis, travel/accommodations/expenses from BMS and is a consultant/advisory board member for BMS. No potential conflicts of interest were disclosed by the other authors.